Focus on eliminating hepatitis hazards and improve the availability of innovative drugs

Viral hepatitis is an important public health problem that endangers human health.

Reducing the burden of hepatitis and increasing the diagnosis and treatment rate is the key

The most harmful viral hepatitis is hepatitis B and hepatitis C.

Our country has the conditions to carry out comprehensive actions to eliminate the harm of viral hepatitis

Wang Yu, chairman of the China Hepatitis Prevention Foundation and distinguished visiting professor of the Vanke School of Public Health and Health of Tsinghua University, pointed out that China has the main conditions to eliminate the harm of viral hepatitis, the key is to pass the society Mobilize and effectively implement various prevention and control measures.

In terms of prevention, Chief Physician Wang Huaqing, Chief Expert of the Immunization Program of the Chinese Center for Disease Control and Prevention (online participation) and Senior Engineer Ma Dongjie, Chairman and General Manager of North China Pharmaceutical Jintan Biotechnology Co.

Professor Yang Xizhong, executive vice chairman of the China Hepatitis Prevention Foundation, believes that the prevention and treatment of hepatitis should adhere to government leadership, departmental collaboration, and social participation; adhere to prevention first, combination of prevention and treatment, prevention and treatment according to law, and scientific prevention; adhere to local conditions, implement policies based on disease, and highlight key points.

It is imperative to launch the "Action to Eliminate Public Health Hazards of Viral Hepatitis"

Inspector Wang Bin of the CDC of the National Health Commission introduced at the meeting that the Chinese government attaches great importance to the prevention and treatment of hepatitis.

At the same time, in the prevention and control of hepatitis B, we must continue to promote the immunization program, and continue to do a good job in blocking mothers and babies.

Improving the accessibility of innovative drugs is the top priority of hepatitis prevention and treatment

The use of innovative antiviral drugs is the most effective way to reduce the burden of hepatitis.

In response, Professor Wang Guiqiang, former chairman of the Infectious Diseases Branch of the Chinese Medical Association, pointed out the current application of hepatitis B antiviral drugs and pointed out that the goal of chronic hepatitis B treatment is to inhibit the replication of hepatitis B for a long time and reduce liver cells.

Professor Jia Jidong from Beijing Friendship Hospital affiliated to Capital Medical University (online participant) pointed out: The new crown epidemic has made people aware of the urgency of curbing the epidemic of infectious diseases.

Professor Xu Xiaoyuan, Chairman of the Chinese Medical Association Hepatology Branch and Peking University First Hospital, said: The key to the diagnosis and treatment of viral hepatitis is to reduce the long-term harm of the virus to the human body, thereby reducing the incidence and mortality of hepatitis-related cirrhosis and liver cancer.

Integrate resources to accelerate the implementation of viral hepatitis elimination plan

During the forum, the China Hepatitis Prevention and Treatment Foundation, Hainan Provincial Health Commission and Gilead (Shanghai) Pharmaceutical Technology Co.

Director Zhou Changqiang of the Hainan Provincial Health Commission and Secretary-General Li Zengde of the China Hepatitis Prevention and Treatment Foundation both stated that the establishment of a viral hepatitis prevention and control cooperation mechanism is an important step to curb the harm of viral hepatitis and is also a concrete practice to comprehensively promote the construction of a healthy China.

This event is the first cooperation between the China Hepatitis Prevention Foundation and the Boao Forum for Asia Global Health Forum, an international exchange and cooperation platform integrating Boao's pragmatic cooperation and the expert resources of the China Hepatitis Prevention Foundation in the field of liver disease, focusing on national hepatitis prevention policies and opportunities Conduct in-depth dialogues and discussions on topics such as challenges, successful experiences at home and abroad, research and development and application of innovative drugs; at the same time, use the media channels of both parties to disseminate knowledge and concepts on the prevention and treatment of hepatitis and eliminate the hazards of hepatitis to all sectors of the society, and jointly contribute to the Healthy China Action and The early realization of the World Health Organization's goal of eliminating the harm of viral hepatitis.